Logo for Exagen Inc

Exagen Investor Relations Material

Latest events

Logo for Exagen Inc

Q4 2023

Exagen
Logo for Exagen

Q4 2023

18 Mar, 2024
Logo for Exagen

Q3 2023

13 Nov, 2023
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies

Latest reports from Exagen Inc

Access all reports
Exagen Inc. is a biotechnology company that develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. The company's AVISE HemaVision tests are used to detect blood clots and other vascular conditions such as arterial plaques. Its AVISE OncoVision tests are clinically validated immunoassay products indicated for the detection of prostate cancer and other solid tumor antigens, as well as for facilitating primary care physicians’ early detection of cancer.